Diplomat Pharmacy (DPLO) Misses Q4 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. AAPL
6. MRVL
7. CL
8. TFII
9. ORCL
10. LYB

Go back to Diplomat Pharmacy (DPLO) Misses Q4 EPS by 9c

Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance

February 28, 2017 4:16 PM EST

FLINT, Mich., Feb. 28, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter and year ended December 31, 2016.  All comparisons, unless otherwise noted, are to the quarter or year ended December 31, 2015.

Fourth Quarter 2016 Highlights include:

Revenue of $1,145 million, an increase of 16% or $158 million 4% organic revenue growth Total prescriptions dispensed of 242,000, an increase of 2% Gross margin of 7.3% versus 7.8% Gross profit per prescription dispensed... More